CClinicalTrials.gg
RecruitingNCT07480057Updated Mar 19, 2026

Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry

An observational study in Chronic Liver Disease and ACLF, sponsored by Institute of Liver and Biliary Sciences, India. Recruiting at 1 site in India. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by Institute of Liver and Biliary Sciences, India · Observational

From the registry’s dates

  • Started Mar 2026; still recruiting 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Liver transplantation (LT) remains the ultimate option to cure intractable end stage liver disease. Nutritional deficiencies are very common among CLD patients and due to this these patients suffer from low bone mineral density leading to osteoporosis and osteopenia. It has been observed that there is substantial reduction in bone density , especially within the first year of LT. The incidence of fractures among LT recipients has been reported to be around 3.5% with vertebral spine being the most common site. Multiple risk factors for osteoporosis after LT has been identified. Some of these include female sex, DM, sedentary lifestyle, pretransplant hypogonadism, Vit-D deficiency and pre-existing bone mineral abnormalities. Patients with CLD are also reported as having osteoblastic dysfunction by many factors, like unconjugated hyperbilirubinemia, decreased synthesis of collagen matrix, and decreased availability of insulin like growth factors. Post-transplant factors among LT recipients include: choice of immunosuppressive therapy like Glucocorticoid and CNIs therapy.

This Observational study aims to analyze the changes in bone mineral metabolism After Liver Transplantation by Bone Mineral Densitometry preoperatively and postoperatively. All eligible adult patients with Chronic Liver Disease undergoing Liver Transplant during the study period will be included in the study. These patients bone mineral density will be assessed using DEXA scan both preop and on Post op at 3 and 6 months. The association between the changes in BMM and various variables such as the sex of the patients, age of patients, etiology of CLD, presence of hepatocellular carcinoma (HCC), ICU stay, Hospital stay will be studied.

Pre-operative, intra-operative and post-operative data will be collected from medical records, electronic hospital information system (HIS) and radiological images collected from the hospital Picture archiving and communication system(PACS). The enrolled subjects will be followed up till for a period of 6 months after the Liver Transplant and the bone mineral density will be compared between these patients along with other parameters.

02

Conditions studied

  • Chronic Liver Disease and ACLF
03

In context

Lead sponsor

Institute of Liver and Biliary Sciences, India is the lead sponsor of 296 studies on the registry; 84 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

all CLD and ACLF patients irrespective of etiology undergoing living donor liver transplant

Inclusion criteria

- All adult patients >18 yrs with Cirrhosis of Liver undergoing Live Donor Liver Transplant

Exclusion criteria

Exclusion Criteria:

  1. Patients not giving consent.
  2. LT for ALF
  3. Pediatric LT recipients
  4. DDLT recipients
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • CLD

    All chronic liver disease undergoing living donor liver transplant.

    Other: no intervention

  • ACLF

    All acute on chronic liver failure patients undergoing living donor liver transplant.

    Other: no intervention

Interventions

  • Otherno intervention

    No intervention as this is an observational study

06

What researchers measure

Primary outcomes

  1. assessment of changes in bone mineral mass (BMM) after living donor liver transplant

    Time frame: preoperative and at 3 months and 6 months post LDLT

Secondary outcomes

  1. evaluate the association between the changes in BMM and gender

    Time frame: preoperative and at 3 months and 6 months post LDLT

  2. evaluate the association between the changes in BMM and age of patients

    Time frame: preoperative and at 3 months and 6 months post LDLT

  3. evaluate the association between the changes in BMM and presence of hepatocellular carcinoma (HCC)

    Time frame: preoperative and at 3 months and 6 months post LDLT

  4. evaluate the association between the changes in BMM and etiology

    Time frame: preoperative and at 3 months and 6 months post LDLT

  5. evaluate the association between the changes in BMM with ICU stay and Hospital stay

    Time frame: preoperative and at 3 months and 6 months post LDLT

07

Study locations

1 of 1 sites recruiting
  • Institute of Liver and Biliary Sciences
    New Delhi, National Capital Territory of Delhi 110070, India
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07480057
Lead sponsor
Institute of Liver and Biliary Sciences, India
Responsible party
Sponsor
First posted
Mar 18, 2026
Start date
Mar 18, 2026
Primary completion
Oct 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Mar 19, 2026

Study contacts

Rahul shivhare, MS
Contact
rahulshivhare93@gmail.com
01146300000
Viniyendra Pamecha, FRCS
Contact
viniyendra@gmail.com
01146300000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion